Table 3.
Interactor | Function | Tumor-Specific Interactome | Role 1 | Mechanism | Roles of DDX3X/DDX5 in the Same Tumor 1 | Ref. |
---|---|---|---|---|---|---|
RPA2 | ss DNA-binding protein | Breast Cancer | + | NF-κB activation | +/+ | [92,93] |
CTCF | Transcriptional coactivator | Breast Cancer | − | Regulation of transcription | +/+ | [94,95] |
DHX9 | RNA/DNA helicase | Breast Cancer | + | Upregulation of lncRNA | +/+ | [96,97] |
CUL1 | Ubiquitination cofactor | Breast Cancer | + | Positive regulation of proliferation | +/+ | [98] |
CUL5 | Ubiquitination cofactor | Breast Cancer | − | Negative regulation of proliferation | +/+ | [99] |
YBX1 | Transcription factor | Breast Cancer | + | Interaction with lncRNA AC073352.1 | +/+ | [100] |
RPS6KB2 | Protein kinase | Breast Cancer | + | Activation of estrogen receptor-alpha | +/+ | [101,102] |
AGR2 | Disulfide isomerase | Breast Cancer | + | Aberrant protein maturation in the ER | +/+ | [103,104] |
YY1 | Transcription factor | Cervical cancer | Dual | Gene-specific recruitment of transcriptional activators or repressors | ?/+ | [105] |
CHD4 | Chromatin remodeling | Endometrial cancer | − | Activation of the TGF-β pathway | ?/+ | [106] |
TAF15 | mRNA metabolism | Gastric cancer | + | Modulation of stress response | −/+ | [107] |
MATR3 | DNA/RNA-binding protein | Lung cancer | + | Undetermined | Dual/+ | [108,109,110] |
DYRK2 | Protein kinase | Glioblastoma | − | Negative regulation of cell migration | +/+ | [111] |
PINK1 | Mitochondrial protein kinase | Glioblastoma | − | Negative regulation of oxidative stress | +/+ | [112] |
SYNCRIP | RNA-binding protein | Leukemia | + | Activation of oncogenes | +/+ | [113] |
ITGA4 | Integrin | Leukemia | + | Upregulation of BCL-2/negative regulation of apoptosis | +/+ | [114] |
MED12 | Protein kinase | Prostate cancer | + | Activation of Wnt/β-catenin and TGF-β signaling | +/+ | [115] |
CNEPA | Kinetochore subunit | Liver cancer | + | Aberrant chromosomal segregation | ?/− | [116] |
1 (+) oncogene, (−) oncosuppressor; (dual) oncogene or oncosuppressor in different studies; (?), role unknown.